PortalPublikationenQuality of Psoriasis Care in Germany: Results of the Nationa...

Quality of Psoriasis Care in Germany: Results of the National Health Care Study "Psohealth3"

Standard

Quality of Psoriasis Care in Germany: Results of the National Health Care Study "Psohealth3". / Langenbruch, Anna; Radtke, Marc Alexander; Jacobi, Arnd; Purwins, Sandra; Haack, Kristina; Reich, Kristian; Stroemer, Klaus; Mrowietz, Ulrich; Augustin, Matthias.

in: ARCH DERMATOL RES, Jahrgang 308, Nr. 6, 08.2016, S. 401-408.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Langenbruch, A, Radtke, MA, Jacobi, A, Purwins, S, Haack, K, Reich, K, Stroemer, K, Mrowietz, U & Augustin, M 2016, 'Quality of Psoriasis Care in Germany: Results of the National Health Care Study "Psohealth3"', ARCH DERMATOL RES, Jg. 308, Nr. 6, S. 401-408. https://doi.org/10.1007/s00403-016-1651-x

APA

Langenbruch, A., Radtke, M. A., Jacobi, A., Purwins, S., Haack, K., Reich, K., Stroemer, K., Mrowietz, U., & Augustin, M. (2016). Quality of Psoriasis Care in Germany: Results of the National Health Care Study "Psohealth3". ARCH DERMATOL RES, 308(6), 401-408. https://doi.org/10.1007/s00403-016-1651-x

Vancouver

Langenbruch A, Radtke MA, Jacobi A, Purwins S, Haack K, Reich K et al. Quality of Psoriasis Care in Germany: Results of the National Health Care Study "Psohealth3". ARCH DERMATOL RES. 2016 Aug;308(6):401-408. https://doi.org/10.1007/s00403-016-1651-x

Bibtex

@article{4f5f0c24e82e4696bbff9b4dcf565824,
title = "Quality of Psoriasis Care in Germany: Results of the National Health Care Study {"}Psohealth3{"}",
abstract = "Two national surveys conducted in 2005 and 2007 indicated deficits in psoriasis care and induced the composition of the ''National Goals for Health Care in Psoriasis 2010-2015''. The aim of this work was to (1) evaluate the quality of care for patients with psoriasis in Germany, (2) compare this with prior psoriasis studies PsoHealth1 (2005) and PsoHealth2 (2007), and (3) review the implementation of national treatment goals. By means of a cross sectional study the following indicators of health care quality were collected: psoriasis severity (Psoriasis Area Severity Index (PASI) and proportion of PASI >20), quality of life (Dermatology Life Quality Index (DLQI) were corporated: proportion of DLQI >10), previous systemic treatment, inpatient treatment, and days absent from work due to psoriasis. Between January 2013 and March 2014, 1265 patients from 82 dermatological centres were included (mean age of 52 years). 9.2 % had a PASI >20 (2007: 11.6 %; 2005: 17.8 %). 21.3 % reported strong quality of life restrictions (DLQI >10) (2007: 28.2 %; 2005: 34.0 %). 59.5 % had received a systemic treatment at least once within the last 5 years (2007: 47.3 %; 2005: 32.9 %). 20.1 % were treated inpatient within the last 5 years (2007: 20.1 %; 2005: 26.9 %). The current data indicate a better health care situation for psoriasis in Germany. The implementation of the S3-Guideline and the ''National Goals for Health Care in Psoriasis 2010-2015'' could have been contributing factors.",
keywords = "Cross-Sectional Studies, Female, Germany, Health Care Surveys, Humans, Male, Middle Aged, Outcome and Process Assessment (Health Care), Practice Guidelines as Topic, Psoriasis, Quality Indicators, Health Care, Quality of Life, Severity of Illness Index, Socioeconomic Factors, Surveys and Questionnaires, Journal Article, Multicenter Study",
author = "Anna Langenbruch and Radtke, {Marc Alexander} and Arnd Jacobi and Sandra Purwins and Kristina Haack and Kristian Reich and Klaus Stroemer and Ulrich Mrowietz and Matthias Augustin",
year = "2016",
month = aug,
doi = "10.1007/s00403-016-1651-x",
language = "English",
volume = "308",
pages = "401--408",
journal = "ARCH DERMATOL RES",
issn = "0340-3696",
publisher = "Springer",
number = "6",

}

RIS

TY - JOUR

T1 - Quality of Psoriasis Care in Germany: Results of the National Health Care Study "Psohealth3"

AU - Langenbruch, Anna

AU - Radtke, Marc Alexander

AU - Jacobi, Arnd

AU - Purwins, Sandra

AU - Haack, Kristina

AU - Reich, Kristian

AU - Stroemer, Klaus

AU - Mrowietz, Ulrich

AU - Augustin, Matthias

PY - 2016/8

Y1 - 2016/8

N2 - Two national surveys conducted in 2005 and 2007 indicated deficits in psoriasis care and induced the composition of the ''National Goals for Health Care in Psoriasis 2010-2015''. The aim of this work was to (1) evaluate the quality of care for patients with psoriasis in Germany, (2) compare this with prior psoriasis studies PsoHealth1 (2005) and PsoHealth2 (2007), and (3) review the implementation of national treatment goals. By means of a cross sectional study the following indicators of health care quality were collected: psoriasis severity (Psoriasis Area Severity Index (PASI) and proportion of PASI >20), quality of life (Dermatology Life Quality Index (DLQI) were corporated: proportion of DLQI >10), previous systemic treatment, inpatient treatment, and days absent from work due to psoriasis. Between January 2013 and March 2014, 1265 patients from 82 dermatological centres were included (mean age of 52 years). 9.2 % had a PASI >20 (2007: 11.6 %; 2005: 17.8 %). 21.3 % reported strong quality of life restrictions (DLQI >10) (2007: 28.2 %; 2005: 34.0 %). 59.5 % had received a systemic treatment at least once within the last 5 years (2007: 47.3 %; 2005: 32.9 %). 20.1 % were treated inpatient within the last 5 years (2007: 20.1 %; 2005: 26.9 %). The current data indicate a better health care situation for psoriasis in Germany. The implementation of the S3-Guideline and the ''National Goals for Health Care in Psoriasis 2010-2015'' could have been contributing factors.

AB - Two national surveys conducted in 2005 and 2007 indicated deficits in psoriasis care and induced the composition of the ''National Goals for Health Care in Psoriasis 2010-2015''. The aim of this work was to (1) evaluate the quality of care for patients with psoriasis in Germany, (2) compare this with prior psoriasis studies PsoHealth1 (2005) and PsoHealth2 (2007), and (3) review the implementation of national treatment goals. By means of a cross sectional study the following indicators of health care quality were collected: psoriasis severity (Psoriasis Area Severity Index (PASI) and proportion of PASI >20), quality of life (Dermatology Life Quality Index (DLQI) were corporated: proportion of DLQI >10), previous systemic treatment, inpatient treatment, and days absent from work due to psoriasis. Between January 2013 and March 2014, 1265 patients from 82 dermatological centres were included (mean age of 52 years). 9.2 % had a PASI >20 (2007: 11.6 %; 2005: 17.8 %). 21.3 % reported strong quality of life restrictions (DLQI >10) (2007: 28.2 %; 2005: 34.0 %). 59.5 % had received a systemic treatment at least once within the last 5 years (2007: 47.3 %; 2005: 32.9 %). 20.1 % were treated inpatient within the last 5 years (2007: 20.1 %; 2005: 26.9 %). The current data indicate a better health care situation for psoriasis in Germany. The implementation of the S3-Guideline and the ''National Goals for Health Care in Psoriasis 2010-2015'' could have been contributing factors.

KW - Cross-Sectional Studies

KW - Female

KW - Germany

KW - Health Care Surveys

KW - Humans

KW - Male

KW - Middle Aged

KW - Outcome and Process Assessment (Health Care)

KW - Practice Guidelines as Topic

KW - Psoriasis

KW - Quality Indicators, Health Care

KW - Quality of Life

KW - Severity of Illness Index

KW - Socioeconomic Factors

KW - Surveys and Questionnaires

KW - Journal Article

KW - Multicenter Study

U2 - 10.1007/s00403-016-1651-x

DO - 10.1007/s00403-016-1651-x

M3 - SCORING: Journal article

C2 - 27206971

VL - 308

SP - 401

EP - 408

JO - ARCH DERMATOL RES

JF - ARCH DERMATOL RES

SN - 0340-3696

IS - 6

ER -